Self-reported herpes zoster, pain, and health care seeking in the Health and Retirement Study: Implications for interpretation of health care-based studies

Annals of Epidemiology

Volumn 26, Issue 6, 2016, Pages 441-446.e3

  Hales, Craig M ^a,b   Harpaz, Rafael ^a   Bialek, Stephanie R ^a,c  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Epidemiologic methods; Health care seeking behavior; Health surveys; Herpes zoster; Medical records; Pain; Population surveillance; Risk factors

Indexed keywords

AGE; AGED; CROSS-SECTIONAL STUDY; ETHNOLOGY; FEMALE; HEALTH SURVEY; HERPES ZOSTER; HUMAN; INDEPENDENT LIVING; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PAIN; PAIN MEASUREMENT; PATHOPHYSIOLOGY; PATIENT ATTITUDE; REPRODUCIBILITY; RETIREMENT; RISK ASSESSMENT; SELF REPORT; SEVERITY OF ILLNESS INDEX; SEX FACTOR; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; UNITED STATES; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HERPES ZOSTER; HUMANS; INDEPENDENT LIVING; LOGISTIC MODELS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PAIN; PAIN MEASUREMENT; PATIENT ACCEPTANCE OF HEALTH CARE; REPRODUCIBILITY OF RESULTS; RETIREMENT; RISK ASSESSMENT; SELF REPORT; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84969980382     PISSN: 10472797     EISSN: 18732585     Source Type: Journal    
DOI: 10.1016/j.annepidem.2016.04.006     Document Type: Article

References (46)

1. Yawn B.P., Saddier P., Wollan P.C., St Sauver J.L., Kurland M.J., Sy L.S. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 2007, 82(11):1341-1349.
2. Kilgore P.E., Kruszon-Moran D., Seward J.F., Jumaan A., Van Loon F.P., Forghani B., et al. Varicella in Americans from NHANES III: implications for control through routine immunization. J Med Virol 2003, 70(Suppl 1):S111-S118.
3. Brisson M., Edmunds W.J., Law B., Gay N.J., Walld R., Brownell M., et al. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect 2001, 127(2):305-314.
4. Brisson M., Edmunds W.J. Epidemiology of Varicella-Zoster Virus in England and Wales. J Med Virol 2003, 70(Suppl 1):S9-S14.
5. Donahue J.G., Choo P.W., Manson J.E., Platt R. The incidence of herpes zoster. Arch Intern Med 1995, 155(15):1605-1609.
6. Insinga R.P., Itzler R.F., Pellissier J.M., Saddier P., Nikas A.A. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med 2005, 20(8):748-753.
7. Mullooly J.P., Riedlinger K., Chun C., Weinmann S., Houston H. Incidence of herpes zoster, 1997-2002. Epidemiol Infect 2005, 133(2):245-253.
8. Russell M.L., Schopflocher D.P., Svenson L., Virani S.N. Secular trends in the epidemiology of shingles in Alberta. Epidemiol Infect 2007, 135(6):908-913.
9. Ragozzino M.W., Melton L.J., Kurland L.T., Chu C.P., Perry H.O. Population-based study of herpes zoster and its sequelae. Medicine 1982, 61(5):310-316.
10. Leung J., Harpaz R., Molinari N.A., Jumaan A., Zhou F. Herpes zoster incidence among insured persons in the United States, 1993-2006: evaluation of impact of varicella vaccination. Clin Infect Dis 2011, 52(3):332-340.
11. Tseng H.F., Smith N., Harpaz R., Bialek S.R., Sy L.S., Jacobsen S.J. Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease. JAMA 2011, 305(2):160-166.
12. Hales C.M., Harpaz R., Joesoef M.R., Bialek S.R. Examination of links between herpes zoster incidence and childhood varicella vaccination. Ann Intern Med 2013, 159(11):739-745.
13. Juster F.T., Suzman R.M. An Overview of the Health and Retirement Study. J Hum Resour 1995, 30:S7-S56. (special issue on the Health and Retirement Study: data quality and early results).
14. Coplan P.M., Schmader K., Nikas A., Chan I.S., Choo P., Levin M.J., et al. Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory. J Pain 2004, 5(6):344-356.
15. Bouhassira D., Chassany O., Gaillat J., Hanslik T., Launay O., Mann C., et al. Patient perspective on herpes zoster and its complications: An observational prospective study in patients aged over 50 years in general practice. Pain 2012, 153(2):342-349.
16. Marin M., Yawn B.P., Hales C.M., Wollan P.C., Bialek S.R., Zhang J., et al. Herpes zoster vaccine effectiveness and manifestations of herpes zoster and associated pain by vaccination status. Hum Vaccin Immunother 2015, 11(5):1157-1164.
17. Bieler G.S., Brown G.G., Williams R.L., Brogan D.J. Estimating model-adjusted risks, risk differences, and risk ratios from complex survey data. Am J Epidemiol 2010, 171(5):618-623.
18. Graubard B.I., Korn E.L. Predictive margins with survey data. Biometrics 1999, 55(2):652-659.
19. Health and Retirement Study, Sample Sizes and Response Rates 2011, University of Michigan, Available from:, [Accessed July 2, 2013]. http://hrsonline.isr.umich.edu/sitedocs/sampleresponse.pdf.
20. Paek E., Johnson R. Public awareness and knowledge of herpes zoster: results of a global survey. Gerontology 2010, 56(1):20-31.
21. Chaves S.S., Santibanez T.A., Gargiullo P., Guris D. Chickenpox exposure and herpes zoster disease incidence in older adults in the U.S. Public Health Rep 2007, 122(2):155-159.
22. Fleiss J.L. Statistical Methods for Rates and Proportions 1981, John Wiley & Sons, New York. 2nd ed.
23. Yawn B.P., Wollan P., St Sauver J. Comparing shingles incidence and complication rates from medical record review and administrative database estimates: how close are they?. Am J Epidemiol 2011, 174(9):1054-1061.
24. Schmader K., George L.K., Newton R., Hamilton J.D. The accuracy of self-report of herpes zoster. J Clin Epidemiol 1994, 47(11):1271-1276.
25. Straus S.E., Ostrove J.M., Inchauspe G., Felser J.M., Freifeld A., Croen K.D., et al. NIH conference. Varicella-zoster virus infections. Biology, natural history, treatment, and prevention. Ann Intern Med 1988, 108(2):221-237.
26. Harpaz R., Ortega-Sanchez I.R., Seward J.F. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2008, 57(RR-5):1-30. quiz CE2-4.
27. Schmader K., George L.K., Burchett B.M., Pieper C.F., Hamilton J.D. Racial differences in the occurrence of herpes zoster. J Infect Dis 1995, 171(3):701-704.
28. Schmader K., George L.K., Burchett B.M., Pieper C.F. Racial and psychosocial risk factors for herpes zoster in the elderly. J Infect Dis 1998, 178(Suppl 1):S67-S70.
29. Thomas S.L., Hall A.J. What does epidemiology tell us about risk factors for herpes zoster?. Lancet Infect Dis 2004, 4(1):26-33.
30. Katz J., Cooper E.M., Walther R.R., Sweeney E.W., Dworkin R.H. Acute pain in herpes zoster and its impact on health-related quality of life. Clin Infect Dis 2004, 39(3):342-348.
31. Anderson K.O., Green C.R., Payne R. Racial and ethnic disparities in pain: causes and consequences of unequal care. J Pain 2009, 10(12):1187-1204.
32. Cohen J.I. Herpes zoster. N Engl J Med 2013, 369(18):1766-1767.
33. Dworkin R.H., Nagasako E.M., Johnson R.W., Griffin D.R. Acute pain in herpes zoster: the famciclovir database project. Pain 2001, 94(1):113-119.
34. Parruti G., Tontodonati M., Rebuzzi C., Polilli E., Sozio F., Consorte A., et al. Predictors of pain intensity and persistence in a prospective Italian cohort of patients with herpes zoster: relevance of smoking, trauma and antiviral therapy. BMC Med 2010, 8:58.
35. Drolet M., Brisson M., Levin M.J., Schmader K.E., Oxman M.N., Johnson R.W., et al. A prospective study of the herpes zoster severity of illness. Clin J pain 2010, 26(8):656-666.
36. Lu P.J., Euler G.L., Jumaan A.O., Harpaz R. Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors. Vaccine 2009, 27(6):882-887.
37. Bowsher D. The lifetime occurrence of Herpes zoster and prevalence of post-herpetic neuralgia: A retrospective survey in an elderly population. Eur J pain 1999, 3(4):335-342.
38. Soni A., Hill S.C. Average Annual Health Care Use and Expenses for Shingles among the U.S. Civilian Noninstitutionalized Population, 2003-2005. Statistical Brief #194 Rockville, MD 2007, Available from:, [Accessed March 30, 2016]. http://www.meps.ahrq.gov/data_files/publications/st194/stat194.pdf.
39. Oxman M.N., Levin M.J., Johnson G.R., Schmader K.E., Straus S.E., Gelb L.D., et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005, 352(22):2271-2284.
40. Dunlop D.D., Manheim L.M., Song J., Chang R.W. Gender and ethnic/racial disparities in health care utilization among older adults. J Gerontol B Psychol Sci Soc Sci 2002, 57(4):S221-S233.
41. Opstelten W., Van Essen G.A., Schellevis F., Verheij T.J., Moons K.G. Gender as an independent risk factor for herpes zoster: a population-based prospective study. Ann Epidemiol 2006, 16(9):692-695.
42. Fleming D.M., Cross K.W., Cobb W.A., Chapman R.S. Gender difference in the incidence of shingles. Epidemiol Infect 2004, 132(1):1-5.
43. Johnson R. Patient Awareness of Herpes Zoster: the Global Herpes Zoster Survey - a Preliminary Report. Herpes 2006, 13(Suppl 1):40A-41A.
44. Joesoef M.R., Leung J., Harpaz R., Bialek S.R. Potential coding error of herpes zoster (HZ) vaccination and HZ diagnosis in administrative data. Vaccine 2011, 29(11):2008-2009.
45. Fleiss J.L. Statistical Methods for Rates and Proportions 1981, John Wiley & Sons, New York. 2nd ed.
46. Gure T.R., McCammon R.J., Cigolle C.T., Koelling T.M., Blaum C.S., Langa K.M. Predictors of self-report of heart failure in a population-based survey of older adults. Circ Cardiovasc Qual Outcomes 2012, 5(3):396-402.